Radiation therapy and esophageal cancer (Q27026922)

Almhanna K

2

1 reference

Meredith KL

3

1 reference

Biagioli MC

4

1 reference

Chuong MD

5

1 reference

Cruz A

6

1 reference

Hoffe SE

7

1 reference

language of work or name

1 reference

April 2013

1 reference

1 reference

20

1 reference

issue

2

1 reference

page(s)

97-110

1 reference

Global patterns of cancer incidence and mortality rates and trends

cites work

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000203

Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000203

Neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000203

A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000203

Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000203

Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000203

Meta-analysis of neoadjuvant treatment modalities and definitive non-surgical therapy for oesophageal squamous cell cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000203

Radiotherapy alone and chemoradiation for nonmetastatic esophageal carcinoma. A critical review of chemoradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000203

The Role of Radiation Therapy in the Management of Esophageal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000203

Oesophageal squamous cell carcinoma: II. A critical review of radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000203

Low dose preoperative radiotherapy for carcinoma of the oesophagus: results of a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000203

Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000203

Influence of number of metastatic lymph nodes on survival of curative resected thoracic esophageal cancer patients and value of radiotherapy: report of 549 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000203

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000203

Long-term efficacy of perioperative chemoradiotherapy on esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000203

Postoperative chemotherapy vs chemoradiotherapy for thoracic esophageal cancer: a prospective randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000203

Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000203

A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000203

Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000203

Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000203

Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000203

Neoadjuvant chemoradiotherapy for esophageal carcinoma: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000203

Does Barrett's esophagus respond to chemoradiation therapy for adenocarcinoma of the esophagus?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000203

Cryoablation of persistent Barrett's epithelium after definitive chemoradiation therapy for esophageal adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000203

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000203

Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000203

Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000203

Are patients with esophageal cancer who become PET negative after neoadjuvant chemoradiation free of cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000203

Outcomes of patients with esophageal cancer staged with [¹⁸F]fluorodeoxyglucose positron emission tomography (FDG-PET): can postchemoradiotherapy FDG-PET predict the utility of resection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000203

Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000203

Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000203

Multicenter prospective randomized trial comparing standard esophagectomy with chemoradiotherapy for treatment of squamous esophageal cancer: early results from the Chinese University Research Group for Esophageal Cancer (CURE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000203

The safety and usefulness of high-dose-rate endoluminal brachytherapy as a boost in the treatment of patients with esophageal cancer with external beam radiation with or without chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000203

Fractionated high dose rate intraluminal brachytherapy in palliation of advanced esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000203

Prospective randomized trial of HDR brachytherapy as a sole modality in palliation of advanced esophageal carcinoma--an International Atomic Energy Agency study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000203

Long-term results of definitive radiotherapy for stage I esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000203

External beam radiation therapy followed by high-dose-rate brachytherapy for inoperable superficial esophageal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000203

State of the art lecture: EUS for esophageal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000203

The role and clinical value of EUS in a multimodality esophageal carcinoma staging program with CT and positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000203

Endoscopic ultrasound for preoperative staging of esophageal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000203

Systematic review of the staging performance of 18F-fluorodeoxyglucose positron emission tomography in esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000203

Choice of radiotherapy planning modality influences toxicity in the treatment of locally advanced esophageal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000203

Analysis of dose-volume parameters predicting radiation pneumonitis in patients with esophageal cancer treated with 3D-conformal radiation therapy or IMRT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000203

Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000203

A nomogram to predict radiation pneumonitis, derived from a combined analysis of RTOG 9311 and institutional data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000203

Fraction size and dose parameters related to the incidence of pericardial effusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000203

Consequences of additional use of PET information for target volume delineation and radiotherapy dose distribution for esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000203

Pre-operative estimation of esophageal tumor metabolic length in FDG-PET images with surgical pathology confirmation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000203

Determination of respiratory motion for distal esophagus cancer using four-dimensional computed tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000203

Implications of respiratory motion as measured by four-dimensional computed tomography for radiation treatment planning of esophageal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000203

Esophageal motion during radiotherapy: quantification and margin implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000203

Clinical utility of 4D FDG-PET/CT scans in radiation treatment planning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000203

Stability of endoscopic ultrasound-guided fiducial marker placement for esophageal cancer target delineation and image-guided radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000203

Four-dimensional computed tomographic analysis of esophageal mobility during normal respiration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000203

Evaluation of respiratory-induced target motion for esophageal tumors at the gastroesophageal junction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000203

Impact of gastric filling on radiation dose delivered to gastroesophageal junction tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000203

Helical tomotherapy for radiotherapy in esophageal cancer: a preferred plan with better conformal target coverage and more homogeneous dose distribution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000203

Feasibility of tomotherapy to reduce normal lung and cardiac toxicity for distal esophageal cancer compared to three-dimensional radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000203

Proton therapy in the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000203

Clinical results of fractionated proton therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000203

Intensity-modulated proton therapy further reduces normal tissue exposure during definitive therapy for locally advanced distal esophageal tumors: a dosimetric study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000203

Four-dimensional computed tomography-based treatment planning for intensity-modulated radiation therapy and proton therapy for distal esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107327481302000203